Advertisement
U.S. markets closed

Sinopharm Group Co. Ltd. (SHTDY)

Other OTC - Other OTC Delayed Price. Currency in USD
12.79-0.24 (-1.84%)
At close: 03:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.03
Open12.77
Bid0.00 x 0
Ask0.00 x 0
Day's Range12.77 - 12.81
52 Week Range11.35 - 18.01
Volume6,163
Avg. Volume13,819
Market Cap7.997B
Beta (5Y Monthly)0.84
PE Ratio (TTM)6.36
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.57 (4.49%)
Ex-Dividend DateJun 15, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SHTDY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SINOPHARM GROUP CO. LTD. UNSP A
    VIR: What does Argus have to say about VIR?VIR BIOTECHNOLOGY INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more